Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Crescent Biopharma (CBIO) Other Non Operating Income (2016 - 2025)

Crescent Biopharma (CBIO) has disclosed Other Non Operating Income for 6 consecutive years, with $1.3 million as the latest value for Q3 2025.

  • Quarterly Other Non Operating Income changed N/A to $1.3 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $749634.0 through Sep 2025, up 100.86% year-over-year, with the annual reading at $651212.0 for FY2017, 528.3% up from the prior year.
  • Other Non Operating Income for Q3 2025 was $1.3 million at Crescent Biopharma, up from -$760000.0 in the prior quarter.
  • The five-year high for Other Non Operating Income was $1.3 million in Q3 2025, with the low at -$760000.0 in Q2 2025.